UNITEDHEALTH GROUP INC (UNH.DE) Fundamental Analysis & Valuation

FRA:UNH • US91324P1021

Current stock price

301.4 EUR
-1.6 (-0.53%)
Last:

This UNH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. UNH.DE Profitability Analysis

1.1 Basic Checks

  • In the past year UNH was profitable.
  • In the past year UNH had a positive cash flow from operations.
  • In the past 5 years UNH has always been profitable.
  • Each year in the past 5 years UNH had a positive operating cash flow.
UNH.DE Yearly Net Income VS EBIT VS OCF VS FCFUNH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • UNH has a better Return On Assets (3.85%) than 75.00% of its industry peers.
  • UNH's Return On Equity of 11.59% is fine compared to the rest of the industry. UNH outperforms 71.43% of its industry peers.
  • UNH has a Return On Invested Capital (5.02%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for UNH is above the industry average of 5.73%.
Industry RankSector Rank
ROA 3.85%
ROE 11.59%
ROIC 5.02%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.86%
ROE(5y)20.71%
ROIC(3y)8.98%
ROIC(5y)9.66%
UNH.DE Yearly ROA, ROE, ROICUNH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • UNH's Profit Margin of 2.68% is in line compared to the rest of the industry. UNH outperforms 57.14% of its industry peers.
  • UNH's Profit Margin has declined in the last couple of years.
  • UNH has a Operating Margin of 4.19%. This is comparable to the rest of the industry: UNH outperforms 46.43% of its industry peers.
  • UNH's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.19%
PM (TTM) 2.68%
GM N/A
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
UNH.DE Yearly Profit, Operating, Gross MarginsUNH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. UNH.DE Health Analysis

2.1 Basic Checks

  • UNH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for UNH has been reduced compared to 1 year ago.
  • UNH has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for UNH has been reduced compared to a year ago.
UNH.DE Yearly Shares OutstandingUNH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
UNH.DE Yearly Total Debt VS Total AssetsUNH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B

2.2 Solvency

  • The Debt to FCF ratio of UNH is 3.98, which is a good value as it means it would take UNH, 3.98 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of UNH (3.98) is better than 82.14% of its industry peers.
  • UNH has a Debt/Equity ratio of 0.69. This is a neutral value indicating UNH is somewhat dependend on debt financing.
  • UNH has a Debt to Equity ratio of 0.69. This is in the better half of the industry: UNH outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.98
Altman-Z N/A
ROIC/WACC0.58
WACC8.64%
UNH.DE Yearly LT Debt VS Equity VS FCFUNH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.3 Liquidity

  • UNH has a Current Ratio of 0.89. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of UNH (0.89) is comparable to the rest of the industry.
  • A Quick Ratio of 0.89 indicates that UNH may have some problems paying its short term obligations.
  • UNH has a Quick ratio of 0.89. This is comparable to the rest of the industry: UNH outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
UNH.DE Yearly Current Assets VS Current LiabilitesUNH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. UNH.DE Growth Analysis

3.1 Past

  • UNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.56%.
  • The Earnings Per Share has been decreasing by -0.67% on average over the past years.
  • Looking at the last year, UNH shows a quite strong growth in Revenue. The Revenue has grown by 9.67% in the last year.
  • The Revenue has been growing by 11.72% on average over the past years. This is quite good.
EPS 1Y (TTM)-41.56%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%0.42%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%1.96%

3.2 Future

  • UNH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.88% yearly.
  • Based on estimates for the next years, UNH will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y10.55%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
EPS Next 5Y15.88%
Revenue Next Year-1.61%
Revenue Next 2Y0.98%
Revenue Next 3Y2.65%
Revenue Next 5Y3.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UNH.DE Yearly Revenue VS EstimatesUNH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200B 400B 600B
UNH.DE Yearly EPS VS EstimatesUNH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

2

4. UNH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 21.61, which indicates a rather expensive current valuation of UNH.
  • UNH's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, UNH is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 17.61, which indicates a rather expensive current valuation of UNH.
  • 67.86% of the companies in the same industry are cheaper than UNH, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, UNH is valued a bit cheaper.
Industry RankSector Rank
PE 21.61
Fwd PE 17.61
UNH.DE Price Earnings VS Forward Price EarningsUNH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UNH is valued a bit more expensive than 75.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UNH indicates a slightly more expensive valuation: UNH is more expensive than 60.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 15.85
UNH.DE Per share dataUNH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates UNH does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as UNH's earnings are expected to grow with 13.68% in the coming years.
PEG (NY)2.05
PEG (5Y)N/A
EPS Next 2Y10.88%
EPS Next 3Y13.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. UNH.DE Dividend Analysis

5.1 Amount

  • UNH has a Yearly Dividend Yield of 2.49%. Purely for dividend investing, there may be better candidates out there.
  • UNH's Dividend Yield is a higher than the industry average which is at 1.64.
  • Compared to an average S&P500 Dividend Yield of 1.81, UNH pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.49%

5.2 History

  • The dividend of UNH is nicely growing with an annual growth rate of 12.43%!
Dividend Growth(5Y)12.43%
Div Incr Years6
Div Non Decr Years6
UNH.DE Yearly Dividends per shareUNH.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • 66.50% of the earnings are spent on dividend by UNH. This is not a sustainable payout ratio.
  • UNH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP66.5%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
UNH.DE Yearly Income VS Free CF VS DividendUNH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B
UNH.DE Dividend Payout.UNH.DE Dividend Payout, showing the Payout Ratio.UNH.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNH.DE Fundamentals: All Metrics, Ratios and Statistics

UNITEDHEALTH GROUP INC

FRA:UNH (4/24/2026, 7:00:00 PM)

301.4

-1.6 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-21
Earnings (Next)07-27
Inst Owners84.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap273.57B
Revenue(TTM)449.71B
Net Income(TTM)12.04B
Analysts75.88
Price Target313.24 (3.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Yearly Dividend7.42
Dividend Growth(5Y)12.43%
DP66.5%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.08%
Min EPS beat(2)-0.58%
Max EPS beat(2)8.74%
EPS beat(4)2
Avg EPS beat(4)0.43%
Min EPS beat(4)-9.92%
Max EPS beat(4)8.74%
EPS beat(8)5
Avg EPS beat(8)0.26%
EPS beat(12)9
Avg EPS beat(12)1.29%
EPS beat(16)13
Avg EPS beat(16)1.93%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.6%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-0.91%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.31%
PT rev (1m)-2.09%
PT rev (3m)-9.38%
EPS NQ rev (1m)2.4%
EPS NQ rev (3m)5.92%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-3.49%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-3.05%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 17.61
P/S 0.71
P/FCF 16.37
P/OCF 13.9
P/B 3.08
P/tB 3.08
EV/EBITDA 15.85
EPS(TTM)13.95
EY4.63%
EPS(NY)17.12
Fwd EY5.68%
FCF(TTM)18.41
FCFY6.11%
OCF(TTM)21.69
OCFY7.2%
SpS423.03
BVpS97.73
TBVpS97.73
PEG (NY)2.05
PEG (5Y)N/A
Graham Number175.143 (-41.89%)
Profitability
Industry RankSector Rank
ROA 3.85%
ROE 11.59%
ROCE 6.15%
ROIC 5.02%
ROICexc 5.59%
ROICexgc 19.97%
OM 4.19%
PM (TTM) 2.68%
GM N/A
FCFM 4.35%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.86%
ROE(5y)20.71%
ROIC(3y)8.98%
ROIC(5y)9.66%
ROICexc(3y)9.97%
ROICexc(5y)10.8%
ROICexgc(3y)28.02%
ROICexgc(5y)30.44%
ROCE(3y)11.07%
ROCE(5y)11.9%
ROICexgc growth 3Y-21.25%
ROICexgc growth 5Y-12.15%
ROICexc growth 3Y-19.22%
ROICexc growth 5Y-11.85%
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.98
Debt/EBITDA 3.08
Cap/Depr 80.55%
Cap/Sales 0.78%
Interest Coverage 250
Cash Conversion 99.55%
Profit Quality 162.5%
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z N/A
F-Score6
WACC8.64%
ROIC/WACC0.58
Cap/Depr(3y)84.55%
Cap/Depr(5y)83.03%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.86%
Profit Quality(3y)129.12%
Profit Quality(5y)123.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.56%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%0.42%
EPS Next Y10.55%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
EPS Next 5Y15.88%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%1.96%
Revenue Next Year-1.61%
Revenue Next 2Y0.98%
Revenue Next 3Y2.65%
Revenue Next 5Y3.86%
EBIT growth 1Y-43.73%
EBIT growth 3Y-12.63%
EBIT growth 5Y-3.28%
EBIT Next Year29.57%
EBIT Next 3Y17.04%
EBIT Next 5Y15.62%
FCF growth 1Y86.12%
FCF growth 3Y-12.42%
FCF growth 5Y-4.82%
OCF growth 1Y66.07%
OCF growth 3Y-9.63%
OCF growth 5Y-2.7%

UNITEDHEALTH GROUP INC / UNH.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?

ChartMill assigns a fundamental rating of 4 / 10 to UNH.DE.


Can you provide the valuation status for UNITEDHEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to UNITEDHEALTH GROUP INC (UNH.DE). This can be considered as Overvalued.


What is the profitability of UNH stock?

UNITEDHEALTH GROUP INC (UNH.DE) has a profitability rating of 4 / 10.


How financially healthy is UNITEDHEALTH GROUP INC?

The financial health rating of UNITEDHEALTH GROUP INC (UNH.DE) is 5 / 10.


Can you provide the dividend sustainability for UNH stock?

The dividend rating of UNITEDHEALTH GROUP INC (UNH.DE) is 6 / 10 and the dividend payout ratio is 66.5%.